ONdrugDelivery provides specialized B2B information for the drug delivery industry, self-described as a source for insights and trends in the field.

ONdrugDelivery

ONdrugDelivery | 2,909 followers on LinkedIn. We know drug delivery | ONdrugDelivery provides &gt;30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. 

Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. 

Subscribe online today to the print or free digital edition.

Guy Furness

Marketing Manager at ONdrugDelivery Magazine

Audrey Furness

Editor of ONdrugDelivery

James Arnold

✨ Formosa Pharmaceuticals, Inc. is thrilled to announce that our breakthrough case study, *"Improving Aerosol Delivery: Nanosuspension and Mesh Technology,"* led by Dr. YuChi Chen, our Director of Nanotechnology Development, has been published in the latest * ONdrugDelivery * Issue No. 167! A huge thanks to our partners at HCmed Innovations Co., Ltd. for collaborating with us to demonstrate how APNT nanoparticle technology enables efficient suspension delivery using the advanced AdheResp smart breath-actuated mesh nebulizer. This publication marks an exciting milestone in aerosol delivery innovation! ✨ Learn More - https://shorturl.at/HITPj #APNT #AdheResp #ONdrugDelivery #Nanosuspension

Formosa Pharmaceuticals, Inc.

Excellent work by the talented team behind URSATEC GmbH !! Thank you ONdrugDelivery for the opportunity. Read all about our work regarding Breease® and give your child a great start in life!

Fredrik Bokvist

#ICYMI : In their #ExpertView piece in the ONdrugDelivery November issue of Pulmonary & Nasal Drug Delivery, Beyond Air's Chief Commercial Officer, David Webster, and VP of Clinical Affairs, Mark Rimkus RRT, P.Eng, explore how generating nitric oxide (NO) at the bedside could address the environmental challenges posed by traditional generation methods. 🌎 Read the full article here ➡️ https://lnkd.in/gwwEQdMt Check out the entire issue here ➡️ https://lnkd.in/dVTzC3WP #BeyondAir #RespiratoryCare #Innovation #NitricOxide #Sustainability #PatientCare

Beyond Air®

The latest ONdrugDelivery is out! - Issue 167, Nov 2024, focuses 100% on "PULMONARY & NASAL DRUG DELIVERY" from cover-to-cover. Read it here 👉 https://lnkd.in/dVTzC3WP Opening with nasal delivery, Mark Ignaczak of Catalent Pharma Solutions provides an overview of the current nasal delivery landscape and what to consider when choosing a CDMO to ensure nasal product programme success. Then a series of articles highlight a diverse range of pulmonary delivery devices. Hernan Cuevas Brun and Yuchi Chen discuss how the combination of Formosa Pharmaceuticals, Inc. ’s patented APNT nanotechnology formulation platform with HCmed Innovations Co., Ltd. ’s AdheResp smart breath-actuated nebuliser can enhance respiratory drug delivery empower developers to deliver difficult solution-based formulations to the lung reliably. Fredrik Bokvist of VivoLab AB introduces the Breease pacifier – a solution to the effects of air pollution on young children and infants – and, along with Marie-Christine Klein and Christian Weyler , looks forward to combining Breease with URSATEC GmbH ’s Softbreezer inhaler to enhance the technology with moisturising therapy. In their interview, Julien Storz-Sontheimer and Giulia Müller , discuss Aptar Pharma ’s PureHale system for delivering a fine mist to the upper airways, including its reception by consumers and applications in the current respiratory landscape. Andrea Cusack , Elijah Nazarzadeh , and John Pritchard provide insights into Nebu~Flow ’s innovative nebuliser platform based on patented ultrasound technology, covering how nebulisers are well positioned to fulfil unmet needs in the respiratory market and how Nebu~Flow aims to tackle the factors that may have thus far held them back. Looking at the new USP <1604> chapter, Clair Brooks of Copley Scientific contributes an in-depth overview of how these changes to the regulatory landscape affect the gathering and analysis of cascade impactor data. Sustainability also features prominently, with Alastair Willoughby of Team Consulting tackling decarbonising drug delivery in an interview discussing his talk at CHPI 2024. In their Expert View piece, David Webster and Mark Rimkus RRT, P.Eng of Beyond Air® discuss how generating NO at patient’s bedsides could be the solution to tackling the environmental challenges presented by current generation methods. The issue also contains a robust look at HFA-152a and HFO-1234ze, the primary low-GWP candidates to replace current pMDI propellants, with articles from Ross Errington and Simon Gardner at Bespak ; Nicholas Smalley at Kindeva Drug Delivery ; and, in an Expert View, Mark Parry , John McLaughlin, and Tino Otte of Intertek Melbourn each offering their own valuable insight into this topical issue. Access the full issue's content here 👉 https://lnkd.in/dVTzC3WP #drugdelivery #inhalation #respiratory #nasalspray #nebuliser #mdi #inhalers #devices

LIVE! We are excited to announce that our article "Trace Analytical Considerations when Reformulating pMDIs with Next-Generation Low-GWP Propellant Systems" is now published in Issue #167 of ONdrugDelivery , November 2024, “Pulmonary & Nasal Drug Delivery”, In this Expert View, Mark Parry , Senior Scientific Director, John McLaughlin, Principal Scientist, and Tino Otte , Technical Expert, discuss the necessary studies required to understand the nitrosamine formation and leachables profiles of new pMDI propellants with lower global warming potentials as part of the pharmaceutical industry’s drive to reduce its emissions and environmental impact. Read the full article online now - page 48: https://lnkd.in/eAd8AcjM #Inhalation #DrugDevelopment #DrugDelivery #Pharmaceutical #Intertek

Intertek Melbourn

Published online: "IT’S TIME TO CONSIDER INTRADERMAL DELIVERY". Read the full ONdrugDelivery article 👉 https://lnkd.in/e8bwSqBG " Nicky Bertollo , Adam Rock and Saidhbh O'Callaghan discuss the progress Pharma Latch ’s intradermal drug delivery platform is making towards realising the potential the intradermal route offers to drug developers, especially for vaccines."

Published online: "NOLATO’S VIRTUAL FACTORY". Read the full ONdrugDelivery article 👉 https://lnkd.in/eyrqnFVY " Patrik Ingvarsson , showcases Nolato ‘s virtual factory, highlighting the advantages of virtual tools for product development in the medical device industry."

PharmaEd Resources have released their 2025 schedule of conferences👇 We’re very pleased to be media partners - Kim Hubbard and her team put on great events and are wonderful to work with. Roll on 2025 - when both PharmaEd and ONdrugDelivery celebrate our 20th Anniversaries!! https://lnkd.in/exXjZxmn

Published online: "ALTAVISC: EXPANDING THE DELIVERY WINDOW FOR HIGH-VISCOSITY & HIGH-VOLUME DRUGS". Read the full ONdrugDelivery article 👉 https://lnkd.in/eKqRXkuJ " Nelson Quintana discusses how altaviz, llc ‘s AltaVISC delivery technology reaps the benefits of gas-powered drive systems over traditional spring-based systems for autoinjectors to offer a highly flexible platform technology for drug developers, allowing them to optimise their formulations within a wider range of delivery device specifications. "

Published online: "INTERVIEW with Scott Ariagno, EdgeOne Medical". Read the full ONdrugDelivery interview 👉 https://lnkd.in/ep3xEVHR " Scott Ariagno talks exclusively with ONdrugDelivery‘s Guy Furness about the role that contract development organisations play in the drug delivery industry ecosystem and how independent expertise can enable companies like EdgeOne Medical to troubleshoot and accelerate product development by bringing fresh eyes, an unbiased perspective and extensive expertise to bear on a development project. Mr Ariagno goes into detail on the unique advantages that EdgeOne can offer over others in the field."

ONDR

COM:ONDRUGDELIVERY

ONdrugDelivery

name

homepage url

country

linkedin url

crunchbase url

sector

industry

monthly webtraffic

monthly webtraffic growth

Description

competitor of

Metrics